October 26, 2017 by Chain Drug Review
Commission on Combating Drug Addiction and the Opioid Epidemic, CVS Health, Healthcare Distribution Alliance, John Gray, John Hammergren, Larry Merlo, McKesson, Melania Trump, opioid abuse crisis, opioid abuse epidemic, President Donald Trump, President's Commission on Combating Drug Addiction and the Opioid Crisis, Stefano Pessina, video, Walgreens Boots Alliance
Leading Headlines, Pharmacy, Retail News, Videos
WASHINGTON — Following through on pledge made this summer, President Donald Trump has formally declared the nation’s growing opioid abuse epidemic as a public health emergency. In a press conference at the White House on Thursday, the president and First Lady Melania Trump announced the action, which has drawn plaudits from public officials and pharmacy
October 18, 2017 by Bill Schiffner
Anthem Inc., Anthem's pharmacy business, Brian Griffin, CVS Caremark, CVS Health, CVS Pharmacy, Express Scripts, IngenioRx, Larry Merlo, MinuteClinic, pharmacy benefit manager
Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health has signed a five-year agreement to provide services to support IngenioRx, a new pharmacy benefit manager formed by Blue Cross Blue Shield health insurer Anthem Inc. CVS said Wednesday that its CVS Caremark PBM division will manage certain services for IngenioRx, including claims processing and prescription fulfillment. In addition, CVS
October 13, 2017 by Chain Drug Review
American Pharmacists Month, CVS Caremark, CVS Health, CVS pharmacists, CVS Pharmacy, CVS Specialty, Larry Merlo, National Pharmacy Technician Day, Omnicare, ScriptPath
Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health is honoring the patient care efforts of its 30,000 pharmacists as part of the annual American Pharmacists Month observation in October. CVS noted that its pharmacy teams are playing an increasingly important role in helping people lead healthier live by improving access to care and lowering costs for the millions
October 9, 2017 by Bill Schiffner
CVS Caremark, CVS Health, CVS Health Foundation, CVS Pharmacy, Larry Merlo, Medication Disposal for Safer Communities Program, opioid abuse, opioid painkillers, opioid utilization management
2017, Issue 10-09-2017, Issues, News
WOONSOCKET, R.I. — CVS Health unveiled a major plan that utilizes all its integrated pharmacy assets to help combat misuse and abuse of opioid painkillers. The retailer said that its enterprisewide strategy to fight the opioid epidemic includes initiatives for safe drug disposal and utilization management of pain medications, as well as increased funding for
September 21, 2017 by Bill Schiffner
CVS Caremark, CVS Health, CVS Health Foundation, CVS Pharmacy, Larry Merlo, Medication Disposal for Safer Communities Program, National Drug Control Policy, opioid abuse, opioid epidemic, opioid prescribing, Pharmacists Teach, prescription drug abuse, Prescription Opioid and Heroin Epidemic Awareness Week, Richard Baum, Troyen Brennan, video
Featured Articles, Leading Headlines, Pharmacy, Retail News, Videos
WOONSOCKET, R.I — CVS Health has unveiled a sweeping plan that marshals its integrated pharmacy assets to help stem the rising tide of drug misuse and abuse, namely opioid painkillers. CVS said Thursday that its enterprisewide strategy to fight the opioid epidemic includes initiatives for safe drug disposal and utilization management of pain medications, as
August 19, 2017 by Geoff Walden and Chain Drug Review
CVS Health, Jon Roberts, Larry Merlo, medication adherence, Transform Diabetes Care
2017, Issue 08-21-2017, Issues, News
WOONSOCKET, R.I. — CVS Health plans to extend its Transform Diabetes Care initiative to four more disease states over the next two years. The program is expected to also cover asthma, hypertension, hypercholesterolemia and depression by midsummer 2019. Launched late last year, Transform Diabetes Care is designed to lower pharmacy costs through aggressive trend management
August 11, 2017 by Geoff Walden and Chain Drug Review
CVS Health, Jon Roberts, Larry Merlo, Transform Diabetes Care
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health plans to extend its Transform Diabetes Care initiative to four more disease states over the next two years. The program is expected to also cover asthma, hypertension, hypercholesterolemia and depression by midsummer 2019. Launched late last year, Transform Diabetes Care is designed to lower pharmacy costs through aggressive trend management
August 8, 2017 by Bill Schiffner
CVS Health, Larry Merlo
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health beat Wall Street’s earnings forecast for the second quarter and bumped up the bottom of its 2017 guidance despite declined sales in its retail pharmacy business unit. CVS said Tuesday that net income for the second quarter ended June 30 totaled $1.1 billion, or $1.07 per diluted share (GAAP), compared
July 21, 2017 by CDR Blog and Chain Drug Review
CVS Health, CVS MinuteClinic, Gina Raimondo, Larry Merlo, National Governors Association 2017 summer meeting, Office of National Drug Control Policy, opioid abuse, Richard Baum
CDR Blog
CVS Health president and CEO Larry Merlo recently shared his insights on health care with the nation’s governors. At the National Governors Association 2017 summer meeting in Providence, R.I., Merlo explained how elements of CVS’ integrated model — with retail/long-term care pharmacy, pharmacy benefits management and walk-in clinic unit — could be applied within states
June 5, 2017 by Scot Meyer and Chain Drug Review
corporate social responsibility, CVS Health, CVS Pharmacy, Larry Merlo, MinuteClinic
2017, Issue 06-05-2017, Issues, News
WOONSOCKET, R.I. — Expanding its offerings of healthier food and beverages and removing parabens and other such ingredients from its store brand beauty and personal care products were two of the many accomplishments highlighted in CVS Health’s 10th annual corporate social responsibility (CSR) report, released last month. Titled “Prescription for a Better World,” the report
May 2, 2017 by Chain Drug Review
CVS Health, CVS Pharmacy, Larry Merlo
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — Despite declines in its retail pharmacy business, CVS Health saw sales rise and beat Wall Street’s earnings projections for its fiscal 2017 first quarter. CVS said Tuesday that for the quarter ended March 31, revenue totaled $44.51 billion, up 3% from $43.22 billion a year earlier. Sales in the company’s Retail/LTC Segment, which
April 22, 2017 by Greg Jacobson and Chain Drug Review
CVS Health, Larry Merlo, Thomas Moriarty
2017, Issue 04-24-2017, Issues, News
WOONSOCKET, R.I. — CVS Health has appointed Thomas Moriarty to the new position of chief policy and external affairs officer. He had been executive vice president, general counsel and chief strategy officer. In addition, CVS has consolidated corporate communications, legal, government affairs and public policy into one operating unit under Moriarty, who continues to report
April 22, 2017 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, CVS Health, Jeffrey Woldt, Larry Merlo, Medicaid reimbursements, National Association of Chain Drug Stores, National Community Pharmacists Association, Tom Moriarty
2017, Issue 04-24-2017, Issues, Opinion
CVS Health earlier this month named Tom Moriarty to the new position of chief policy and external affairs officer. As explained by president and chief executive officer Larry Merlo, the rationale behind the creation of the role is to “deliver an integrated approach to policy development and external engagement so the company can contribute to
April 6, 2017 by Chain Drug Review
CVS Health, Larry Merlo, Thomas Moriarty
Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health has named Thomas Moriarty as chief policy and external affairs officer, a newly created position. CVS said Thursday that Moriarty, who has served as executive vice president and general counsel, will bring corporate communications, legal, government affairs and public policy under a single operating unit to manage the company’s external